Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Working Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 1.161.121.080.991.02

What is the latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) is 1.16 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20261.16
Mar20251.12
Mar20241.08
Mar20230.99
Mar20221.02

How is Working Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2026 1.16
3.57
Mar2025 1.12
3.70
Mar2024 1.08
9.09
Mar2023 0.99
-2.94
Mar2022 1.02 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Working Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹256.5 Cr -0.7% -8.7% -19.9% Stock Analytics
KAVERI SEED COMPANY ₹3,763.3 Cr 2.9% 3.9% -31.2% Stock Analytics
VENKYS (INDIA) ₹2,428.9 Cr 7.6% 4.3% 14.9% Stock Analytics
AVT NATURAL PRODUCTS ₹1,518.6 Cr 2.9% 17.1% 46.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,005.9 Cr 6.1% 6.5% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹560.6 Cr 5% 9.4% 1.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-0.7%

-8.7%

-19.9%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses